PRAME-like 4 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the PRAME-like 4 protein, a member of the PRAME (Preferentially Expressed Antigen in Melanoma) family of proteins. The PRAME family is known to be involved in various cellular processes, particularly those related to gene regulation. PRAME-like 4 is thought to play a role in transcriptional repression, likely through interactions with other regulatory proteins or transcription factors. By binding to these regulatory components, PRAME-like 4 may modulate gene expression patterns that are crucial for maintaining cellular function. Inhibitors of PRAME-like 4 function by blocking its ability to interact with these transcriptional complexes, thereby altering its role in gene regulation.
Using PRAME-like 4 inhibitors in research helps scientists investigate the specific molecular mechanisms underlying its role in transcriptional regulation. These inhibitors allow researchers to explore how the disruption of PRAME-like 4 activity impacts cellular gene expression profiles, shedding light on its contributions to broader regulatory networks. By inhibiting PRAME-like 4, scientists can examine changes in protein interactions, chromatin remodeling, and overall transcriptional control within the cell. Additionally, studying these inhibitors provides insights into how PRAME-like 4 fits into the complex network of proteins that regulate gene expression, offering a deeper understanding of its role in maintaining cellular homeostasis and responding to environmental signals. This research ultimately helps unravel the precise functions of PRAME-like 4 in cellular processes such as differentiation, proliferation, and signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent may cause hypomethylation of the PRAME like-4 promoter region, consequently increasing gene transcription, thereby potentially increasing PRAME like-4 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid potentially leads to hyperacetylation of histones associated with the PRAME like-4 gene locus, which could loosen chromatin structure and inadvertently promote gene expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram might inhibit aldehyde dehydrogenase, which could create a cellular state that inadvertently increases PRAME like-4 gene transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, 5-Aza-2′-Deoxycytidine may decrease methylation at the PRAME like-4 gene promoter, potentially resulting in higher levels of transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA, Mithramycin A might block the binding sites for transcription factors that control the PRAME like-4 gene, which could unintentionally enhance its transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could activate retinoic acid receptors that bind to the PRAME like-4 promoter region, potentially promoting transcription of the gene. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may inhibit the transcription of several genes, including PRAME like-4, which could lead to a decrease in its mRNA and protein levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might interfere with specific transcription factor pathways that are involved in the transcriptional activation of the PRAME like-4 gene, inadvertently amplifying its expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could activate sirtuins that indirectly lead to the transcriptional enhancement of the PRAME like-4 gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate may cause hyperacetylation of histones at the PRAME like-4 gene locus, potentially increasing the transcriptional activity of the gene. | ||||||